Witnessing the stock’s movement on the chart, on Wednesday, CureVac N.V (NASDAQ: CVAC) had a quiet start as it plunged -6.78% to $2.75, before settling in for the price of $2.95 at the close. Taking a more long-term approach, CVAC posted a 52-week range of $2.21-$6.24.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 54.58%. Meanwhile, its Annual Earning per share during the time was -23.15%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 168.82%. This publicly-traded company’s shares outstanding now amounts to $224.34 million, simultaneously with a float of $93.63 million. The organization now has a market capitalization sitting at $616.84 million. At the time of writing, stock’s 50-day Moving Average stood at $2.84, while the 200-day Moving Average is $3.16.
CureVac N.V (CVAC) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. CureVac N.V’s current insider ownership accounts for 58.26%, in contrast to 5.18% institutional ownership.
CureVac N.V (CVAC) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
CureVac N.V’s EPS increase for this current 12-month fiscal period is 168.82% and is forecasted to reach -0.54 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -10.76% through the next 5 years, which can be compared against the -23.15% growth it accomplished over the previous five years trading on the market.
CureVac N.V (NASDAQ: CVAC) Trading Performance Indicators
Let’s observe the current performance indicators for CureVac N.V (CVAC). It’s Quick Ratio in the last reported quarter now stands at 6.19. The Stock has managed to achieve an average true range (ATR) of 0.18. Alongside those numbers, its PE Ratio stands at $5.06, and its Beta score is 2.59. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.04. Similarly, its price to free cash flow for trailing twelve months is now 5.45.
In the same vein, CVAC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.54, a figure that is expected to reach -0.22 in the next quarter, and analysts are predicting that it will be -0.54 at the market close of one year from today.
Technical Analysis of CureVac N.V (CVAC)
Going through the that latest performance of [CureVac N.V, CVAC]. Its last 5-days volume of 0.44 million was inferior to the volume of 0.82 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 22.71% While, its Average True Range was 0.19.
Raw Stochastic average of CureVac N.V (CVAC) in the period of the previous 100 days is set at 25.50%, which indicates a major rise in contrast to 3.57% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 62.67% that was higher than 54.16% volatility it exhibited in the past 100-days period.
